Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Peg-interferon plus ribavirin combination therapy in HCV mono-infected and HCV/HIV co-infected patients in Iran

- Hesamizadeh K. , et al.

2. Psychiatric side effects of pegylated interferon-α and ribavirin therapy in iranian patients with chronic hepatitis c: A meta-analysis

- Davoodi L. , et al.

3. MDR1 gene C3435T polymorphism in chronic hepatitis C patients

- Parsa Nahad M. , et al.

4. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection

- Jalilian S. , et al.

5. Clinical correlations between chronic hepatitis C infection and decreasing bone mass density after treatment with interferon-alpha

- Babaei V. , et al.

6. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C

- Wang L.J. , et al.

7. Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline

- Alavian S.M. , et al.

8. Changes in hematological parameters with pegylated interferon in chronic hepatitis C virus infected patients

- Rehman A.U. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.